osimertinib
astrazeneca
['osimertinib', 'lcsm,(-blcsm)']
day 1 of #asco23 is in the books #lcsm #onctwitter, what do we make of neoadjuvant osimertinib s/p the data we have right now? 
Tweeting the latest updates, educational resources, & breakthroughs re: treatment & research of #lungcancer | @adesaimd @fawziaburous @esinghimd | #lcsm #ASCO23